Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma MultiformeFiliz Senbabaoglu, Tugba Bagcı-Önder, Ahmet Cingöz et al.|Cancer Biology & Therapy|2016Cited by 35
Abstract B73: Screen among 1200 FDA-approved drug library reveals mitoxantrone as a TRAIL-sensitizing agent for glioblastoma multiformeFiliz Senbabaoglu, Tugba Bagcı-Önder, Ezgi Kaya-Aksoy et al.|Molecular Cancer Therapeutics|2015Cited by 0
Mitoxantrone as a TRAIL-sensitizing agent for glioblastoma multiformeFiliz Senbabaoglu, Tugba Bagcı-Önder, Ahmet Cingöz et al.|European Journal of Cancer|2016Cited by 0
DDIS-04. MITOXANTRONE POTENTIATES TRAIL-INDUCED APOPTOSIS IN GLIOBLASTOMA MULTIFORMEFiliz Senbabaoglu, Tugba Bagcı-Önder, Ceyda Açılan et al.|Neuro-Oncology|2016Cited by 0